What You Should Know:
– Glytec recently announced that it has been selected by CPS Solutions, LLC (CPS), a leading provider of enterprise pharmacy solutions to hospitals and health systems, to serve as an insulin management technology resource for CPS’ more than 2,200 pharmacy professionals across 800-plus healthcare facilities nationwide.
– Through this collaboration, CPS client facilities may contract for Glytec’s eGlycemic Management System® (eGMS) and Glytec’s technical resources to be available to their healthcare professionals, empowering them to establish best-in-class glycemic management programs.
Using eGlycemic Management Systems To Enhance Patient-Care
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. It is the only provider of cloud-based insulin management software across the continuum of care, and Glytec’s FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations from hospital to home.
Decades of clinical research have shown that optimal glycemic management in the hospital positively impacts patient outcomes and business performance. Glytec’s eGMS® was designed to support these patient and provider demands. The technology centers on Glucommander™, the only cloud-based, FDA-cleared software able to personalize IV and SubQ insulin dosing support for patients with and without diabetes. The suite of tools in the EHR-integrated eGMS platform guides pharmacists and other healthcare providers to achieve best practice care by providing personalized treatment recommendations, identifying and alerting of patients in glycemic disarray, and providing guardrails that enhance patient safety. Studies have shown that keeping patients in target range with Glytec’s eGMS can reduce 30-day readmissions by up to 68% and cut length of stay by up to 3.2 days.
With an understanding of the positive impact that proper insulin management can have on outcomes and cost of care, Centers for Medicare and Medicaid Services (CMS) published two new eCQMs to measure glycemic management outcomes that are designed to address prolonged, untreated high blood sugar and mitigate instances of severe low blood sugar related to insulin management. These challenges cut across disease states and affect every hospital department. While 11% of Americans live with diabetes, nearly 40% of all hospitalized patients require insulin therapy to regulate high blood sugar during their stay. Poorly managed blood sugar as a result of lack of treatment or treatment with dated protocols has resulted in immune dysfunction, higher rates of infection, a longer length of hospital stay, complications and even death.
“As health systems prepare to report on the new CMS hospital harm measures related to glycemic management, it is imperative that pharmacists have the appropriate technology resources to optimize their facility’s insulin dosing,” said Stephanie Ostling Mason, PharmD, CDCES, Diabetes Clinical Pharmacist at Glytec. “The pharmacy department is a key stakeholder in insulin protocols, and the collaboration between Glytec and CPS is a significant step towards achieving the industry’s goal of reducing incidences of dysglycemia and making severe hypoglycemia related to insulin a never event.”